Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study

• Principais autores: Yan Li (Autor), Zhengyuan Hu (Autor), Yufei Guo (Autor), Zheng Zhao (Autor), Kunpeng Li (Autor), Xiuru Wang (Autor), Jie Zhang (Autor), Dongfeng Liang (Autor), Jianglin Zhang (Autor), Xiaoyue Hu (Autor), Jian Zhu (Autor), Feng Huang (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objectives: The impact of non-steroidal anti-inflammatory drugs (NSAIDs), conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and tumor necrosis factor inhibitors (TNFi) on the outcomes of mild-moderate COVID-19 in patients with ankylosing spondylitis (AS) remains unclear. This s...